The 21st century is not only a time of progress in innovative technologies and artificial intelligence, but also a time of global downgrade and early development of serious health disorders, especially oncological and cardiovascular diseases. Currently, various cerebrovascular disorders have become widespread, which are the main limitation factors in rational therapy. This is due to the complications of primary diagnosis of the disease and its confirmation, as well as the problems in the application of early neuroprotection and rehabilitation. The aim of the study. The research of new compound’s neuroprotective properties: the dipotassium salt of N-(3-hydroxybenzoyl)taurine, which is a derivate of hydroxybenzoic acid, by the different types of vascular (blood circulation) disorders in the brain. Materials and methods. The examination of the dipotassium salt of N-(3-hydroxybenzoyl)taurine, as a derivate of hydroxybenzoic acid. Establishing the neurological status using the Combs & D`Alecy scale and the Gracia scale. Results. The research results let to suggest the cerebroprotective properties of a new hydroxybenzoic acid derivate, which demonstrates potential comparable to Citicoline, Nicergoline, and Acetylsalicylic acid in decrease the damage of the neuropsychiatric consequences of ischemic injury. The examine compound, like these other drugs, exhibits properties aimed at stabilizing cerebral circulation and reducing the manifestations of endothelial dysfunction. Conclusions. According to study findings the dipotassium salt of N-(3-hydroxybenzoyl)taurine exhibits cerebroprotective effects in various cerebrovascular disorders.